| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.16 | 0.2 |